Kukje Pharma Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 32,241.18 million compared to KRW 29,626.68 million a year ago. Net income was KRW 1,187.12 million compared to KRW 126.59 million a year ago. Basic earnings per share from continuing operations was KRW 59.0476 compared to KRW 6.3492 a year ago. Diluted earnings per share from continuing operations was KRW 59.0476 compared to KRW 6.3492 a year ago. Basic earnings per share was KRW 59.0476 compared to KRW 6.6667 a year ago.
For the six months, sales was KRW 65,491.94 million compared to KRW 57,010.55 million a year ago. Net income was KRW 3,333.65 million compared to KRW 979.09 million a year ago. Basic earnings per share from continuing operations was KRW 164.7619 compared to KRW 48.5714 a year ago. Diluted earnings per share from continuing operations was KRW 164.7619 compared to KRW 48.5714 a year ago. Basic earnings per share was KRW 164.7619 compared to KRW 48.5714 a year ago.